Sarcoma drug ridaforolimus may improve survival

News
Article

LOS ANGELES (Reuters) - Ariad Pharmaceuticals' experimental cancer drug may improve overall survival in patients with advanced sarcoma, according to data from a phase III trial released Wednesday.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.